Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.490
+0.090 (2.05%)
At close: Apr 15, 2026, 4:00 PM EDT
4.410
-0.080 (-1.78%)
After-hours: Apr 15, 2026, 7:57 PM EDT

TriSalus Life Sciences Revenue

In the year 2025, TriSalus Life Sciences had annual revenue of $45.15M with 53.41% growth. TriSalus Life Sciences had revenue of $13.21M in the quarter ending December 31, 2025, with 59.85% growth.

Revenue (ttm)
$45.15M
Revenue Growth
+53.41%
P/S Ratio
6.11
Revenue / Employee
$442,657
Employees
102
Market Cap
275.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202545.15M15.72M53.41%
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RxSight134.48M
Standard BioTools85.33M
Sight Sciences77.36M
Electromed68.86M
CVRx, Inc.56.65M
908 Devices56.20M
ClearPoint Neuro36.97M
Senseonics Holdings35.26M
Revenue Rankings

TLSI News

More News